Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ferrante

Showing results (201-210 of 246) with videos related to

Pageof 25
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 2, 2004
Prophylactic creatine administration mediates neuroprotection in cerebral ischemia in miceShan Zhu, Mingwei Li, Bryan E Figueroa, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2011
Transcriptional modulator H2A histone family, member Y (H2AFY) marks Huntington disease activity in man and mouseYi Hu, Vanita Chopra, Raman Chopra, et al.
Annals of Neurology|July 18, 2001
Dichloroacetate exerts therapeutic effects in transgenic mouse models of Huntington's diseaseO A Andreassen, R J Ferrante, H M Huang, et al.
Advances in Nutrition (Bethesda, Md.)|October 9, 2025
Upstream Interventions in Clinical Settings Focused on Nutrition to Prevent Obesity During the First 1000 Days: A Scoping ReviewCourtney T Luecking, Chelsea L Kracht, Mackenzie J Ferrante, et al.
The Clinical Neuropsychologist|August 19, 2025
Digital language measures capture episodic memory disruptions in people with human immunodeficiency virus: A machine learning studyLucas Federico Sterpin, Camilo Avendaño Avello, Jeremías Inchauspe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2004
A phase I open label study of the farnesyltransferase inhibitor CP-609,754 in patients with advanced malignant tumorsStacy L Moulder, John J Mahany, Richard Lush, et al.
Frontiers in Bioscience (Elite Edition)|June 2, 2012
A high-throughput screen to identify inhibitors of SOD1 transcriptionPaul D Wright, Nicholas Wightman, Mickey Huang, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 19, 2008
Inhibitors of cytochrome c release with therapeutic potential for Huntington's diseaseXin Wang, Shan Zhu, Zhijuan Pei, et al.
Biochimica Et Biophysica Acta|January 22, 2008
Therapeutic attenuation of mitochondrial dysfunction and oxidative stress in neurotoxin models of Parkinson's diseaseEdward C Stack, Joellyn L Ferro, Jinho Kim, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|August 9, 2008
Phase 2 study of sodium phenylbutyrate in ALSMerit E Cudkowicz, Patricia L Andres, Sally A Macdonald, et al.
Pageof 25

Showing results (201-210 of 246) with videos related to

Sort By:
Pageof 25
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 2, 2004
Prophylactic creatine administration mediates neuroprotection in cerebral ischemia in miceShan Zhu, Mingwei Li, Bryan E Figueroa, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2011
Transcriptional modulator H2A histone family, member Y (H2AFY) marks Huntington disease activity in man and mouseYi Hu, Vanita Chopra, Raman Chopra, et al.
Annals of Neurology|July 18, 2001
Dichloroacetate exerts therapeutic effects in transgenic mouse models of Huntington's diseaseO A Andreassen, R J Ferrante, H M Huang, et al.
Advances in Nutrition (Bethesda, Md.)|October 9, 2025
Upstream Interventions in Clinical Settings Focused on Nutrition to Prevent Obesity During the First 1000 Days: A Scoping ReviewCourtney T Luecking, Chelsea L Kracht, Mackenzie J Ferrante, et al.
The Clinical Neuropsychologist|August 19, 2025
Digital language measures capture episodic memory disruptions in people with human immunodeficiency virus: A machine learning studyLucas Federico Sterpin, Camilo Avendaño Avello, Jeremías Inchauspe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2004
A phase I open label study of the farnesyltransferase inhibitor CP-609,754 in patients with advanced malignant tumorsStacy L Moulder, John J Mahany, Richard Lush, et al.
Frontiers in Bioscience (Elite Edition)|June 2, 2012
A high-throughput screen to identify inhibitors of SOD1 transcriptionPaul D Wright, Nicholas Wightman, Mickey Huang, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 19, 2008
Inhibitors of cytochrome c release with therapeutic potential for Huntington's diseaseXin Wang, Shan Zhu, Zhijuan Pei, et al.
Biochimica Et Biophysica Acta|January 22, 2008
Therapeutic attenuation of mitochondrial dysfunction and oxidative stress in neurotoxin models of Parkinson's diseaseEdward C Stack, Joellyn L Ferro, Jinho Kim, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|August 9, 2008
Phase 2 study of sodium phenylbutyrate in ALSMerit E Cudkowicz, Patricia L Andres, Sally A Macdonald, et al.
Pageof 25